Abstract: In at least one embodiment, the invention includes a method for allowing players to compete over a computer network in non-real time by using performances involving a individual sport, comprising: scheduling at least two performances involving the individual sport, collecting data from the at least two performances wherein the collected data represents results of real performances in the individual sport, and comparing the collected data in a reality-based competition between participants of the at least two performances to determine a winner, even though the actual performances of each competitor may have occurred independent of each other and separate from each other. In other embodiments, the invention also preferably provides one with a statistical report including ranking information which an individual sport participant may utilize to determine his performance strengths and weaknesses.

Abstract: A metal bending machine comprising a lower pinchroller composed of modular interchangeable segments, and upper pinchroller composed of modular interchangeable segments, and a radius roller composed of modular interchangeable segments, the lower pinchroller being fixedly and rotatably mounted upon a pinchroller table, the upper pinchroller being rotatably and vertically adjustably mounted in alignment with and above the lower pinchroller, and the radius roller being rotatably and vertically adjustably mounted upon the pinchroller table behind the upper and lower pinch rollers, the upper and lower pinchrollers being counter-rotated with respect to each other by a rotating means, the segments of the upper and lower pinchrollers and the radius roller having annular channels therearound closely fitted to the cross-sectional profile of a workpiece to be bent by the metal bending machine, the metal workpiece being driven into and through the pinch point formed by the upper and lower pinchrollers, and into contact wi

Abstract: There are described compounds of formula I, ##STR1## in which R.sub.5, R.sub.6, R.sub.7 and R.sub.8, which may be the same or different, are hydrogen, alkyl C2 to 6, alkoxy C2 to 8, hydroxy-alkoxy C3 to 8, and R.sub.5 may be hydroxy, provided that one or two of R.sub.5, R.sub.6, R.sub.7 and R.sub.8 are other than hydrogen, and pharmaceutically acceptable derivatives thereof. The compounds of formula I are indicated for use in the treatment of asthma, and pharmaceutical compositions containing them and processes for their preparation are also described.

Abstract: There are described compounds of formula I, ##STR1## and pharmaceutically acceptable derivatives thereof, in which R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5 and R.sup.6 are the same or are different and each is a hydrogen or halogen atom or an alkyl, hydroxy, alkoxy, or substituted alkyl or alkoxy group, (for example a hydroxy-alkoxy, alkoxyalkoxy or carboxyalkoxy group), and X is a saturated or unsaturated, substituted or unsubstituted, straight or branched hydrocarbon chain which may be interrupted by a carbocyclic or heterocyclic ring, or by one or more oxygen atoms or carbonyl groups. There are also described processes for making the compounds and pharmaceutical compositions, for the treatment of asthma, containing the compounds.

Abstract: There are described compounds of formula I, ##SPC1##in which R.sub.5, R.sub.6, R.sub.7 and R.sub.8, which may be the same or different, are hydrogen, alkyl C2 to 6, alkoxy C2 to 8, hydroxy-alkoxy C3 to 8, and R.sub.5 may be hydroxy, provided that one or two of R.sub.5, R.sub.6, R.sub.7 and R.sub.8 are other than hydrogen,And pharmaceutically acceptable derivatives thereof. The compounds of formula I are indicated for use in the treatment of asthma, and pharmaceutical compositions containing them and processes for their preparation are also described.

Abstract: There are described compounds of formula I, ##SPC1##in whichR.sub.5, r.sub.6, r.sub.7 and R.sub.8, which may be the same or different, are hydrogen, alkyl, halogen, hydroxy, alkenyl, phenyl, alkenyloxy, aralkyl, acyloxy or alkoxy; the alkoxy optionally being substituted by alkoxy, hydroxy, or a heterocyclic ring containing carbon and oxygen; the alkyl, alkenyl and alkoxy groups containing from 1 to 8 carbon atoms, andW is oxygen or sulphur,And pharmaceutically acceptable derivatives thereof.Certain of the compounds in which W is oxygen are excluded. The compounds of formula I are indicated for use in the treatment of asthma, and pharmaceutical compositions containing them and processes for their preparation are also described.